WebTravere Therapeutics. 16,383 followers. 9h. People living with rare kidney disease (RKD) are making their voices heard through the RKD & Me campaign. Amanda recently shared her personal story of ... WebApr 1, 2024 · SAN DIEGO , March 14, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that the Company will present a quantitative systems …
Did you know?
WebOct 13, 2024 · Travere Therapeutics will host a conference call and webcast today, October 13, 2024 at 4:30 p.m. ET to discuss the regulatory update. To participate in the conference call, dial +1-888-254-3590 (U.S.) or +1-929-477-0402 (International), confirmation code 4001801 shortly before 4:30 p.m. ET. WebApr 10, 2024 · Travere Therapeutics, Inc. ClinicalTrials.gov Identifier: NCT03493685 Other Study ID Numbers: 021FSGS16010 : First Posted: April 10, 2024 Key Record Dates: Last Update Posted: October 31, 2024 Last Verified: October 2024 Individual Participant ...
WebApr 11, 2024 · Travere Therapeutics Stock Up 2.6 %. TVTX opened at $21.47 on Monday. The company has a debt-to-equity ratio of 8.76, a quick ratio of 3.37 and a current ratio of … WebTravere Therapeutics has raised $792.5M. When was the last funding round for Travere Therapeutics? Travere Therapeutics closed its last funding round on Feb 28, 2024 from a Post-IPO Equity round. Who are Travere Therapeutics 's competitors? Alternatives and possible competitors to Travere Therapeutics may include Affimed, Editas Medicine, and …
WebApr 12, 2024 · Travere Therapeutics has a beta of 0.46, suggesting that its share price is 54% less volatile than the S&P 500. Comparatively, Hillstream BioPharma has a beta of … WebApr 13, 2024 · SAN DIEGO, April 13, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on April 10, 2024, the Compensation Committee of its Board of Directors granted inducement equity grants to five new employees, consisting of inducement restricted stock units, or RSUs, covering an aggregate of 30,000 shares of its …
WebAug 16, 2024 · Travere Therapeutics will host a conference call and webcast today, Monday, August 16, 2024, at 8:30 a.m. ET to discuss the study results. To participate in the conference call, dial +1 (855) 219-9219 (U.S.) or +1 (315) 625-6891 (International), confirmation code 9558913 shortly before 8:30 a.m. ET.
WebTravere Therapeutics is a biopharmaceutical company whose mission is to identify, develop, and deliver life-changing therapies to people living with rare disease. Learn More . Volume: 52 Week High: 52 Week Low: View Full Stock Info . Data Provided by Refinitiv. Minimum 15 minutes delayed. the salmon schoolWebTravere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SAN DIEGO, March 14, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: … trading in gift cards for moneyWebApr 13, 2024 · SAN DIEGO, April 13, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on April 10, 2024, the Compensation Committee of its Board of Directors granted inducement equity grants to five new employees, consisting of inducement restricted stock units, or RSUs, covering an aggregate of 30,000 shares of its … trading in hong kong under the style ofWeb21 hours ago · Travere Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $37.22, representing a 78.94% upside. In a report released on April 10, Guggenheim also maintained a ... the salmon sharpnessWebFeb 17, 2024 · Travere Therapeutics will host a conference call and webcast today, Friday, February 17, 2024 at 4:30 p.m. ET to discuss the FDA accelerated approval and launch of … trading in gpo robloxWebir.travere.com trading in gold jewelry for cashWeb16 hours ago · Bank of America Securities analyst Greg Harrison maintained a Buy rating on Travere Therapeutics (TVTX – Research Report) today and set a price target of $52.00. … the salmon shirt of seduction hannibal